Department of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.
Department of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia.
Cell Oncol (Dordr). 2023 Jun;46(3):589-602. doi: 10.1007/s13402-022-00763-9. Epub 2022 Dec 26.
Tumor cells thrive by adapting to the signals in their microenvironment. To adapt, cancer cells activate signaling and transcriptional programs and migrate to establish micro-niches, in response to signals from neighboring cells and non-cellular stromal factors. Understanding how the tumor microenvironment evolves during disease progression is crucial to deciphering the mechanisms underlying the functional behavior of cancer cells.
Multiplex immunohistochemistry, spatial analysis and histological dyes were used to identify and measure immune cell infiltration, cell signal activation and extracellular matrix deposition in low-grade, high-grade astrocytoma and glioblastoma.
We show that lower grade astrocytoma tissue is largely devoid of infiltrating immune cells and extracellular matrix proteins, while high-grade astrocytoma exhibits abundant immune cell infiltration, activation, and extensive tissue remodeling. Spatial analysis shows that most T-cells are restricted to perivascular regions, but bone marrow-derived macrophages penetrate deep into neoplastic cell-rich regions. The tumor microenvironment is characterized by heterogeneous PI3K, MAPK and CREB signaling, with specific signaling profiles correlating with distinct pathological hallmarks, including angiogenesis, tumor cell density and regions where neoplastic cells border the extracellular matrix. Our results also show that tissue remodeling is important in regulating the architecture of the tumor microenvironment during tumor progression.
The tumor microenvironment in malignant astrocytoma, exhibits changes in cell composition, cell signaling activation and extracellular matrix deposition during disease development and that targeting the extracellular matrix, as well as cell signaling activation will be critical to designing personalized therapy.
肿瘤细胞通过适应其微环境中的信号而茁壮成长。为了适应环境,癌细胞会激活信号和转录程序,并迁移以建立微生态位,以响应来自邻近细胞和非细胞基质因子的信号。了解肿瘤微环境在疾病进展过程中如何演变对于破译癌症细胞功能行为的机制至关重要。
使用多重免疫组织化学、空间分析和组织学染料来识别和测量低级别、高级别星形细胞瘤和胶质母细胞瘤中的免疫细胞浸润、细胞信号激活和细胞外基质沉积。
我们表明,低级星形细胞瘤组织中基本上没有浸润的免疫细胞和细胞外基质蛋白,而高级星形细胞瘤则表现出丰富的免疫细胞浸润、激活和广泛的组织重塑。空间分析表明,大多数 T 细胞局限于血管周围区域,但骨髓来源的巨噬细胞穿透到富含肿瘤细胞的深部区域。肿瘤微环境的特征是 PI3K、MAPK 和 CREB 信号的异质性,特定的信号谱与不同的病理特征相关,包括血管生成、肿瘤细胞密度和肿瘤细胞与细胞外基质交界的区域。我们的结果还表明,组织重塑在肿瘤进展过程中调节肿瘤微环境的结构中很重要。
恶性星形细胞瘤的肿瘤微环境在疾病发展过程中表现出细胞组成、细胞信号激活和细胞外基质沉积的变化,靶向细胞外基质以及细胞信号激活将是设计个性化治疗的关键。